Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Alnylam Pharmaceuticals (GB:0HD2)

LSE:0HD2

UK Market

0HD2

Alnylam Pharma

Analyst Forecasts

News & Insights

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Alnylam Pharma (0HD2) Stock News & Sentiment

3 Followers

Alnylam Pharmaceuticals: Balancing Promising Pipeline with Competitive Challenges and Strategic Uncertainties

Ratings

Alnylam Pharmaceuticals: Balancing Promising Pipeline with Competitive Challenges and Strategic Uncertainties

13d ago

Alnylam Pharma’s Strategic Advancements and Promising Pipeline Drive Buy Rating

Ratings

Alnylam Pharma’s Strategic Advancements and Promising Pipeline Drive Buy Rating

14d ago

Cautious Hold on Alnylam Pharmaceuticals Amid Promising Pipeline and Pending Approvals

Ratings

Cautious Hold on Alnylam Pharmaceuticals Amid Promising Pipeline and Pending Approvals

14d ago

Alnylam Pharma’s Promising Pipeline and Strategic Advancements Justify Buy Rating

Ratings

Alnylam Pharma’s Promising Pipeline and Strategic Advancements Justify Buy Rating

14d ago

Alnylam Pharma’s Promising Growth Prospects: Buy Rating Backed by Strong Pipeline and Strategic Focus

Ratings

Alnylam Pharma’s Promising Growth Prospects: Buy Rating Backed by Strong Pipeline and Strategic Focus

14d ago

Strategic Growth Potential and Robust Pipeline Reinforce Buy Rating for Alnylam Pharma

Ratings

Strategic Growth Potential and Robust Pipeline Reinforce Buy Rating for Alnylam Pharma

14d ago

Alnylam Pharma’s TTR Franchise Growth and Transition to Nucresiran Drives Buy Rating

Ratings

Alnylam Pharma’s TTR Franchise Growth and Transition to Nucresiran Drives Buy Rating

16d ago

More GB:0HD2 News >

0HD2 News on the Web

2025-03-06

High Growth Tech Stocks Leading The US Market

Yahoo Finance

Neutral

2025-03-05

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Zacks

Neutral

2025-02-25

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day

Yahoo Finance

Neutral

2025-02-18

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag

Yahoo Finance

Neutral

2025-02-14

BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline

Zacks

Neutral

2025-02-14

Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y

Zacks

Neutral

2025-02-14

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

Zacks

Neutral

2025-02-14

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

GB:0HD2

Sector Average

Media Buzz

This Week2 articles

Weekly Average7 articles

News Sentiment

This Week59%

Sector Average53%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0HD2’s Media Buzz Sentiment?

2 articles about GB:0HD2 were published this week. In an average week, 7 articles are published.

What is GB:0HD2’s weekly average amount of articles?

In an average week, 7 articles about GB:0HD2 are published.

What is GB:0HD2’s News Sentiment?

59% of articles about GB:0HD2 were positive this week, compared to its sector average of 53%.

Healthcare Stocks that are Trending in the News

FENCFennec Pharmaceuticals

CKPTCheckpoint Therapeutics

CSBTFKuros Biosciences

PTGXProtagonist Therapeutics

SNOASonoma Pharmaceuticals

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing